Reduced Mean Glucose and Glycemic Variability with Coadministration of Basal-Bolus Pramlintide and Insulin in Type 1 Diabetes (T1D)

被引：0
|
作者：
Riddle, Matthew C.
Nahra, Rajaa
Han, Jenny
Hompesch, Marcus
Huffman, David
Strange, Poul
Ohman, Peter
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1121-P
引用
收藏
页码：A298 / A298
页数：1
相关论文
共 50 条
  • [41] Patterns of Diabetes Distress (DD) and Glycemic Outcomes in Teens with Type 1 Diabetes (T1D)
    Wentzell, Katherine
    Tinsley, Liane J.
    Volkening, Lisa K.
    McGill, Dayna E.
    Anderson-Thomas, Barbara J.
    Laffel, Lori M.
    [J]. DIABETES, 2023, 72
  • [42] Youth at Risk for Type 1 Diabetes (T1D) Disparities: Diabetes Distress and Glycemic Control
    Fegan-Bohm, Kelly
    Butler, Ashley
    Anderson, Barbara J.
    Weissberg-Benchell, Jill
    Titus, Courtney
    Hilliard, Marisa E.
    [J]. DIABETES, 2016, 65 : A201 - A201
  • [43] Institution of Basal-Bolus Therapy at Diagnosis for Children With Type 1 Diabetes Mellitus
    Adhikari, Soumya
    Adams-Huet, Beverley
    Wang, Yu-Chi A.
    Marks, James F.
    White, Perrin C.
    [J]. PEDIATRICS, 2009, 123 (04) : E673 - E678
  • [44] USE OF INSULIN-BOLUS CALCULATOR FREE STYLE INSULINX® IN DIABETES TYPE-1 PATIENTS TREATED WITH BASAL-BOLUS INSULIN REGIMEN
    Delgado, E.
    Tejera, C.
    Bellido, D.
    Morales, F.
    Porca, C.
    Diaz Perez De Madrid, Jose
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A74 - A74
  • [45] Use of insulin degludec, a new basal insulin with an ultra-long duration of action, in basal-bolus therapy in type 1 and type 2 diabetes
    Kerlan, Veronique
    Gouet, Didier
    Marre, Michel
    Renard, Eric
    [J]. ANNALES D ENDOCRINOLOGIE, 2013, 74 (5-6) : 487 - 490
  • [46] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes treating to target with basal insulin
    Riddle, Matthew
    Zhang, Bei
    Maier, Holly
    Wilhelm, Ken
    Kolterman, Orville
    [J]. DIABETES, 2008, 57 : A156 - A156
  • [47] Relationship between Mean Glucose and A1C by Pubertal Stage in Youth with Type 1 Diabetes (T1D)
    Zhu, Jia
    Volkening, Lisa
    Katz, Michelle
    Laffel, Lori M.
    [J]. DIABETES, 2018, 67
  • [48] Pramlintide reduces the risks associated with glucose variability in type 1 diabetes
    Kovatchev, Boris P.
    Crean, John
    McCall, Anthony
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (05) : 391 - 396
  • [49] Comparative Effectiveness of Basal-Bolus Versus Premix Analog Insulin on Glycemic Variability and Patient-Centered Outcomes during Insulin Intensification in Type 1 and Type 2 Diabetes: A Randomized, Controlled, Crossover Trial
    Testa, Marcia A.
    Gill, Jasvinder
    Su, Max
    Turner, Ralph R.
    Blonde, Lawrence
    Simonson, Donald C.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : 3504 - 3514
  • [50] Changes in Basal and Bolus Insulin Requirements During Pramlintide Initiation and Dose Escalation in Young Adults With Type 1 Diabetes
    Weyman, Kate
    Zgorski, Melinda
    Carria, Lori R.
    Sherr, Jennifer L.
    Cengiz, Eda
    Tamborlane, William V.
    Weinzimer, Stuart A.
    [J]. DIABETES, 2012, 61 : A615 - A615
12345